Latest Ratios: P/E Ratio 1.6x · EV/EBITDA -12.1x · ROE 18.1%. (2003–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.3B | $1.4B | $1.5B | $1.7B | $1.6B | $2.3B | $2.5B | — | — | — | — |
| Enterprise Value | $-14035050116 | $-13950015000 | $1.6B | $1.9B | $2.3B | $2.3B | $2.9B | — | — | — | — |
| P/E Ratio → | 1.58 | 1.68 | 1.70 | 1.94 | 1.77 | 2.14 | 3.39 | — | — | — | — |
| P/S Ratio | 0.16 | 0.17 | 0.19 | 0.22 | 0.23 | 0.37 | 0.45 | — | — | — | — |
| P/B Ratio | 0.28 | 0.29 | 0.34 | 0.39 | 0.39 | 0.46 | 0.37 | — | — | — | — |
| P/FCF | 0.95 | 1.01 | 1.48 | 0.87 | 1.49 | 1.40 | 1.17 | — | — | — | — |
| P/OCF | 0.87 | 0.92 | 1.31 | 0.84 | 1.38 | 1.35 | 1.14 | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | -1.71 | 0.20 | 0.26 | 0.34 | 0.37 | 0.53 | — | — | — | — |
| EV / EBITDA | -12.11 | -12.04 | 0.20 | 0.26 | 0.34 | 1.77 | 0.53 | — | — | — | — |
| EV / EBIT | -13.08 | -12.10 | — | — | — | 1.60 | — | — | — | — | — |
| EV / FCF | — | -9.98 | 1.54 | 1.01 | 2.18 | 1.38 | 1.39 | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.3% | 46.3% | 100.0% | 100.0% | 100.0% | 102.7% | 100.0% | 100.0% | 102.3% | 100.9% | 100.7% |
| Operating Margin | 13.1% | 13.1% | 99.5% | 99.5% | 99.5% | 17.7% | 99.2% | 99.2% | 10.4% | 14.0% | 15.0% |
| Net Profit Margin | 10.3% | 10.3% | 11.1% | 11.4% | 13.2% | 22.3% | 13.1% | 15.0% | 7.6% | 7.0% | 10.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 18.1% | 18.1% | 20.3% | 20.5% | 19.8% | 23.6% | 11.2% | 16.0% | 10.3% | 9.3% | 13.4% |
| ROA | 2.7% | 2.7% | 2.9% | 3.2% | 3.7% | 2.9% | 1.1% | 1.4% | 0.9% | 0.9% | 1.3% |
| ROIC | — | — | 131.9% | 119.3% | 104.0% | 13.5% | 64.6% | 85.8% | 12.1% | 17.1% | 16.8% |
| ROCE | 3.4% | 3.4% | 39.2% | 42.3% | 43.1% | 2.8% | 8.8% | 10.2% | 1.4% | 2.0% | 2.2% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.38 | 0.38 | 0.33 | 0.35 | 0.40 | 0.42 | 0.31 | 0.26 | 0.26 | 0.24 | 0.26 |
| Debt / EBITDA | 1.57 | 1.57 | 0.19 | 0.20 | 0.24 | 1.63 | 0.38 | 0.28 | 1.39 | 1.23 | 1.16 |
| Net Debt / Equity | — | -3.19 | 0.02 | 0.06 | 0.18 | -0.01 | 0.07 | -0.11 | -0.04 | -0.19 | -0.17 |
| Net Debt / EBITDA | -13.25 | -13.25 | 0.01 | 0.04 | 0.11 | -0.02 | 0.08 | -0.11 | -0.23 | -0.98 | -0.75 |
| Debt / FCF | — | -10.99 | 0.07 | 0.14 | 0.69 | -0.02 | 0.22 | -0.27 | -0.11 | -0.61 | -0.75 |
| Interest Coverage | 14.41 | 14.41 | 104.86 | 97.58 | 79.69 | 15.20 | 62.86 | 87.16 | 11.31 | 9.52 | 11.22 |
Net cash position: cash ($17.2B) exceeds total debt ($1.8B)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | — | — | 0.25 | 0.45 | 0.39 | 0.65 | 0.45 | 1.76 | 0.72 | 0.75 | 0.80 |
| Quick Ratio | — | — | 0.25 | 0.69 | 0.49 | 0.75 | 0.45 | 2.76 | 1.11 | 1.24 | 1.28 |
| Cash Ratio | — | — | 0.14 | 0.13 | 0.10 | 0.25 | 0.21 | 0.64 | 0.21 | 0.33 | 0.33 |
| Asset Turnover | — | 0.25 | 0.26 | 0.25 | 0.28 | 0.25 | 0.08 | 0.09 | 0.12 | 0.12 | 0.12 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 45.6% | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | 72.0% | 72.0% | 27.4% | 80.3% | 21.5% | 170.8% | 22.0% | 49.5% | 24.0% | 22.9% | 15.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 63.3% | 59.6% | 58.9% | 51.5% | 56.6% | 46.8% | 29.5% | — | — | — | — |
| FCF Yield | 100.0% | 99.0% | 67.7% | 114.8% | 67.3% | 71.5% | 85.4% | — | — | — | — |
| Buyback Yield | 7.5% | — | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 53.0% | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $84M | $84M | $85M | $85M | $86M | $89M | $91M | $91M | $90M | $89M |
Social inflation casualty exposure
As reported in recent financial data, AFGE trades at a P/B ratio of 0.27, a valuation level that appears significantly disconnected from the firm's historical performance and suggests that investors are heavily discounting the company's future underwriting prospects relative to its specialty insurance peers.
The current P/B multiple of 0.27 warrants investigation, as it implies a market perception of either significant hidden liabilities or a lack of confidence in the sustainability of the firm's underwriting margins. This valuation gap compared to peers like RLI or WRB suggests that the market may be pricing in a permanent impairment of the franchise value rather than temporary cyclical volatility.
Based on the provided quarterly figures, AFGE achieved a combined ratio of 81.6% in 2025Q4, which indicates strong underwriting profitability, though the historical volatility in loss ratios suggests that prior-year reserve development is significantly obscuring the true, ongoing performance of the firm's specialty insurance segments.
The combined ratio trajectory demonstrates a commitment to underwriting discipline, yet the extreme swings in loss ratios—including negative values in early 2024—complicate the assessment of core profitability. Investors should monitor whether these fluctuations represent genuine underwriting success or merely the release of conservative reserves established in prior periods.
According to the latest financial statements, AFGE's ROE has fluctuated between 3.5% and 6.4% over the last ten quarters, a trend that appears to be heavily influenced by the interplay between underwriting margins and the investment income generated from the firm's substantial cash and investment pool.
The firm's ability to maintain positive ROE during periods of market volatility suggests that the decentralized underwriting model effectively complements the investment strategy. However, the reliance on investment income to bolster returns may indicate that the core insurance operations are not yet fully optimized to generate consistent, standalone profitability without the support of the float.
As noted in institutional research, AFGE's P/B ratio of 0.27 stands in stark contrast to the higher multiples commanded by specialty peers like RLI and WRB, which suggests that the market may be mispricing the firm's decentralized business model and its long-term capital allocation strategy.
While AFGE shares a similar niche-focused underwriting approach with its peer group, the significant discount in its valuation multiple implies that investors are prioritizing the superior combined ratio consistency of competitors. This valuation disparity warrants further investigation into whether AFGE's specific niche exposures are perceived as higher risk than those of its more highly-valued counterparts.
Based on the provided data, the P/E ratio of 1.57 is the most commonly misapplied metric for AFGE, as it fails to account for the significant volatility introduced by reserve development and investment gains, which frequently distort the firm's true, ongoing underwriting profitability and earnings power.
Using P/E to evaluate an insurer like AFGE is fundamentally flawed because it ignores the critical role of book value and underwriting leverage in the firm's capital structure. Analysts should instead focus on the combined ratio and P/B to better understand the underlying health of the insurance franchise and the true value of the capital backing its reserves.
Includes 30+ ratios · 23 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AFGE stock.
American Financial Group, Inc.'s current P/E ratio is 1.6x. The historical average is 2.1x.
American Financial Group, Inc.'s current EV/EBITDA is -12.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 0.6x.
American Financial Group, Inc.'s return on equity (ROE) is 18.1%. The historical average is 13.0%.
Based on historical data, American Financial Group, Inc. is trading at a P/E of 1.6x. Compare with industry peers and growth rates for a complete picture.
American Financial Group, Inc.'s current dividend yield is 45.56% with a payout ratio of 72.0%.
American Financial Group, Inc. has 46.3% gross margin and 13.1% operating margin. Operating margin between 10-20% is typical for established companies.
American Financial Group, Inc.'s Debt/EBITDA ratio is 1.6x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.